What exactly changed in the CHE analyst rating on Feb 26, 2026

Bank of America downgraded Chemed to **Cautious** on February 26, 2026 and cut its price target to **$450** after a Q4 EBITDA miss and a weaker 2026 outlook.

How should investors interpret the CHE analyst rating downgrade

A Cautious rating signals higher near-term risk and reduced upside. Investors should reassess exposure to Roto-Rooter cash flow and watch for operational updates before making trades.

Did the CHE analyst rating move affect the stock price materially

Yes. The downgrade coincided with a move to a 52-week low and a listed change of **20.58%**, about **$79.92**, as the market adjusted to weaker results.

Where can I read the analyst note and coverage on this CHE analyst rating

The downgrade appears in coverage summarized by StreetInsider and Seeking Alpha, which cite BofA’s note and the cut to a **$450** target [source](https://www.streetinsider.com/Analyst+Comments/BofA+Securities+Downgrades+Chemed+%28CHE%29+to+Neutral+Following+Earnings/26066112.html) [source](https://s

Analyst Ratings

BofA Downgrades Chemed Corporation (CHE) to Cautious Feb 26, 2026

ByHuzaifa Zahoor February 27, 2026

Bank of America Securities downgraded Chemed Corporation (CHE) to Cautious on February 26, 2026. The CHE analyst rating change follows a weaker Roto-Rooter EBITDA and a 2026 EBITDA guide below Street expectations. BofA also cut its price target to $450, citing the Q4 miss and softer 2026 outlook. This single notable downgrade landed after Chemed reported results and prompted immediate market reassessment.